Abstract:Introduction: Adult human cardiomyocytes (CMs) have poor capacity for proliferation and functional recovery after heart attack, thus leading to the high morbidity and mortality of cardiovascular diseases. Thus, there is great need to understand the underlying mechanisms of adult CM turnover and maturation. While screening for modulators of TEAD1, the downstream transcriptional effector of Hippo pathway, my lab identified a novel factor—C5ORF51/RIMOC1—as a potential cardiomyogenic modulator. C5ORF51 (hereinafter referred to as C5x) is a previously uncharacterized protein of nearly unknown function, which appears to play critical roles in the regulation of CM homeostasis and heart size. Hypothesis: C5x is a novel cardiomyogenic regulator which determines CM turnover, maturation, and function. Methods and Results: (1) Ex vivo C5x deletion in mouse neonatal CMs leads to significantly increased percentages of cells in S-G2-M phases, suggesting that C5x mediates CM cell cycle arrest in a cell-autonomous manner; (2) In vivo CM-specific C5x-knockout mouse model shows significantly enhanced CM proliferation in adult mice as well as increased CM endowment and mononuclear diploid populations, indicating that C5x has an essential role in cell replication and division in vivo; (3) With age, C5x-CM-knockout mice develop systolic dysfunction, massive cardiomegaly, late-onset dilated cardiomyopathy, and premature mortality, demonstrating a critical role of C5x in maintaining normal cardiac function; (4) RNA sequencing analysis further reveals that C5x loss-of-function activates fetal gene expression while its gain-of-function suppresses fetal gene expression, suggesting C5x as a gatekeeper of the fetal gene program. Conclusions: C5x is required for CM cell cycle arrest, and its loss results in fetal gene activation leading to a primitive cell state and immature CM expansion.

NFAT5-mediated CACNA1C Expression is Critical for Cardiac Electrophysiological Development and Maturation

NFATc4 and Myocardin Synergistically Up-Regulate the Expression of LTCC Α1c in ET-1-induced Cardiomyocyte Hypertrophy.

The Transcription Factor Foxc1a in Zebrafish Directly Regulates Expression of Nkx2.5, Encoding a Transcriptional Regulator of Cardiac Progenitor Cells

Zebrafish Foxc1a Controls Ventricular Chamber Maturation by Directly Regulating Wwtr1 and Nkx2.5 Expression.

Nfatc1 Coordinates Valve Endocardial Cell Lineage Development Required for Heart Valve Formation.

Nucleoporin 107 Facilitates the Nuclear Export of Scn5a Mrna to Regulate Cardiac Bioelectricity

LRP5 Controls Cardiac QT Interval by Modulating the Metabolic Homeostasis of L-type Calcium Channel.

Nuclear Factor of Activated T Cells-5 Regulates Notochord Lumenogenesis in Chordate Larval Development

CXXC5 is Required for Cardiac Looping Relating to TGFβ Signaling Pathway in Zebrafish.

Nkx2.5: a crucial regulator of cardiac development, regeneration and diseases

Nucleoporin 50 mediates <i>Kcna4</i> transcription to regulate cardiac electrical activity

Critical Role of Znhit1 for Postnatal Heart Function and Vacuolar Cardiomyopathy

Novel enhancers conferring compensatory transcriptional regulation of Nkx2-5 in heart development

WNT signaling promotes Nkx2.5 expression and early cardiomyogenesis via downregulation of Hdac1.

Abstract 18695: C5ORF51/RIMOC1 - A Novel Regulator of Cardiogenesis

LIM and Cysteine-Rich Domains 1 Regulates Cardiac Hypertrophy by Targeting Calcineurin/Nuclear Factor of Activated T Cells Signaling

A Foxf1-Wnt-Nr2f1 cascade promotes atrial cardiomyocyte differentiation in zebrafish

The Cardiac Determination Factor, Nkx2-5, is Activated by Mutual Cofactors GATA-4 and Smad1/4 Via a Novel Upstream Enhancer

Abstract 91: Genome-wide Identification and Characterization of Cardiac Hypertrophy-related Long Noncoding RNAs in Mice

Neural cell adhesion molecule is required for ventricular conduction system development

The long non-coding RNA NEAT1 regulates the transcriptional landscape of cardiomyocytes